Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical profile of systemic sclerosis without a 'scleroderma pattern' at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology.

Journal of translational autoimmunity·2026
Same author

Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

RMD open·2026
Same author

Pegcetacoplan prophylaxis for recurrent C3 glomerulopathy with multifactorial genetic background.

Kidney international·2026
Same author

HLA DRB1*01:02 allele is associated with anti-AT1R antibodies production in kidney transplanted patients.

Human immunology·2026
Same author

Age and onset timing of Raynaud's phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR).

Therapeutic advances in musculoskeletal disease·2026
Same author

New insights into neurodevelopmental disorders by whole genome sequencing of 100 families from Italy.

NPJ genomic medicine·2026
Same journal

Mast Cells and Cardiovascular Disorders.

Current vascular pharmacology·2026
Same journal

Occupational and Environment-Related Cardiovascular Disease: A Comprehensive Review of the Literature.

Current vascular pharmacology·2026
Same journal

Metalloproteinases 2 and 9 as Biomarkers in Acute Elevation of Blood Pressure.

Current vascular pharmacology·2026
Same journal

Is the Cardiovascular Risk Increased in Patients with Isolated Systolic Hypertension and Anemia?

Current vascular pharmacology·2026
Same journal

Periodontal Disease and Cardiovascular Risk Factors.

Current vascular pharmacology·2026
Same journal

The Use of Colchicine in Cardiovascular Disease: Anti-Inflammatory Mechanisms and Clinical Utility.

Current vascular pharmacology·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Hypercoagulability and nephrotic syndrome.

Antonietta Gigante, Biagio Barbano, Liborio Sardo

  • 1Department of Nephrology, "Sapienza" University of Rome, Viale del Policlinico 155, Rome, Italy. biagionet@hotmail.com.

Current Vascular Pharmacology
|June 26, 2012
PubMed
Summary
This summary is machine-generated.

Patients with nephrotic syndrome face high risks of blood clots due to a hypercoagulable state. This review focuses on prophylactic anticoagulation strategies to manage these thromboembolic events, especially when hypoalbuminemia is present.

More Related Videos

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Related Experiment Videos

Last Updated: May 21, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Area of Science:

  • Nephrology
  • Hematology
  • Vascular Medicine

Background:

  • Nephrotic syndrome significantly elevates the risk of thromboembolic events, including deep venous thrombosis, arterial thrombosis, renal vein thrombosis, and pulmonary embolism.
  • This increased thrombotic risk is linked to a "hypercoagulable" state characterized by an imbalance of pro-coagulant and anti-coagulant factors.
  • Hypoalbuminemia, particularly levels below 2 g/dL, is identified as a key independent predictor of thrombotic risk in these patients.

Purpose of the Study:

  • To review current literature on the management of thromboembolic events in patients with nephrotic syndrome.
  • To focus on and suggest optimal prophylactic anticoagulation strategies for this patient population.
  • To address the critical question of whether prophylactic anticoagulation is indicated in patients with nephrotic syndrome.

Main Methods:

  • Systematic review of recent medical literature.
  • Analysis of factors influencing thrombotic risk in nephrotic syndrome.
  • Evaluation of prophylactic and therapeutic anticoagulation strategies.

Main Results:

  • Hypoalbuminemia is a major independent predictor of thrombosis risk.
  • The decision to initiate prophylactic anticoagulation is multifactorial, depending on glomerulonephritis type, proteinuria severity, and patient history.
  • Prophylactic strategies are emphasized for managing thromboembolic risk.

Conclusions:

  • Patients with nephrotic syndrome require careful consideration for anticoagulation due to their hypercoagulable state.
  • Prophylactic anticoagulation should be tailored based on individual risk factors and clinical presentation.
  • Evidence-based recommendations for anticoagulation management in nephrotic syndrome are crucial for preventing thromboembolic complications.